Home >  Registry
     
 
Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Trial information

A randomised trial of NT-proBNP guided patient management in heart failure clinics - A study in the Danish Network of Heart Failure Clinics

Status: Recruiting

Protocol number: P04M101

Sponsor: Roche Diagnostics

Company division: Diagnostic

Brief summary: This study will evaluate assessment of NT-proBNP levels before discharge on management and clinical outcomes in patients admitted with heart failure, and evaluate the use of NT-proBNP measurement in managing the patients followed in a heart failure clinic.

Study type: Interventional study

Condition: Heart Failure

Intervention type: Diagnostic Test

Intervention name: Elecsys®proBNP, Cardiac reader®proBNP

Inclusion criteria:

  • Adult patients ≥18 years of age;
  • Clinical stable heart failure, NYHA I-III.

Exclusion criteria:

  • Candidates for surgical interventions;
  • Severe renal dysfunction.

Gender: Males or Females

Accepts healthy volunteers: No

Anticipated start date: August, 2005

Trial registration date: 08/22/2005

Date last updated: 11/21/2008


Link to trial result

This trial is being conducted at the following locations:

Denmark

  • Various

To contact Roche for more information on this trial please complete the email form below. Treatment decisions and/or suitability for a specific trial are decisions only your healthcare provider can make. If you are patient interested in any of the studies, please have your healthcare provider contact us via this website, and they will be provided with the relevant clinical trial information.

Country*
Are you a:*
Subject*
Last Name*
First Name*
Telephone
E-mail*

your email address is needed for us to reply